AT&T and Pfizer Offer Value and Income, But Face Growth Headwinds

AT&T stock trades at a discount (P/E of 8.84 vs industry average 11.7) and offers a high 6.4% dividend yield

AT&T is cutting costs by $8 billion+ to support its dividend and pay down debt

However, AT&T is expected to see modest 0.8% revenue growth due to competition

Pfizer stock trades at a discount (P/E of 12 vs industry average 17) and offers a 6.2% dividend yield

Pfizer's oncology pipeline could produce new blockbuster drugs, leading to growth despite patent expirations